Product Images Dopamine Hydrochloride

NDC 0143-6252-01 is a dopamine hydrochloride injection of 200 mg per 5 mL (40 mg/mL) in 5 mL single dose vial manufactured and distributed by Hikma Farmaceutica in Portugal. It is sterile, non-pyrogenic, and must be diluted before intravenous administration. Sodium metabisulfite and citrate are added as stabilizers and buffers, respectively. The lot number and expiration date are also provided.*

DOPamine Hydrochloride Injection is an intravenous medication that comes in 25 x 5 ml vials. Each vial contains 200 mg of dopamine hydrochloride, which is equivalent to 40 mg/mL. The medication must be diluted before use. The container should not be used if the solution is darker than slightly yellow or if it has any other discoloration. The standard dose is indicated on the package, and bacterial contamination is not present. The storage temperature should be between 31°C and 25°C. The text includes instructions for opening the vial seal and using the solution with sterile technique. Hikma is the manufacturer of the medicine.*

This is a description of a Dopamine Hydrochloride Injection in a single dose vial, which contains 400 mg of dopamine in 10 mL of liquid. The vial also contains stabilizers and buffers such as sodium metabisulfite, citric acid, and sodium citrate dehydrate. It should be noted that the liquid must be diluted before intravenous use, and the vial is sterile and non-pyrogenic. There is no information about the Lot and Exp number.*

DOPamine Hydrochloride Injection, USP is available in 400 mg per 10 mL (40 mg/mL) concentration. It must be diluted before Intravenous use. The product comes in Single Dose Vials of 2510 mL each, with a concentration of 3%. The package description also contains information about the recommended temperature for storage, and a caution to dilute before use. The text also mentions a brand name "Topin" that may be related to the product in some way.*